# OnCo record convert (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/convert/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "convert", "NCT00433563" ;
  schema:name "CONVERT"@en ;
  schema:description "Settled the radiotherapy schedule debate in limited-stage disease: neither schedule was superior, so twice-daily 45 Gy remains standard and once-daily is an acceptable alternative."@en ;
  schema:url <https://onco.cc/trials/convert/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00433563> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2008-04" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/limited-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:institutions <https://onco.cc/institutions/the-christie/> ;
  onco:terms <https://onco.cc/terms/limited-extensive-stage/> ;
  onco:trials <https://onco.cc/trials/chart-lung/> ;
  onco:people <https://onco.cc/people/corinne-faivre-finn/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-convert-lancet-oncol-2017/>, <https://onco.cc/key-papers/paper-convert-int-j-radiat-oncol-biol-phys-2024-update/> .